Posttransplant lymphoproliferative disorders (PTLD) are a rare, but serious complication following transplantation. Late-onset PTLD are often associated with more monoclonal lesions and consequently have a worse prognosis. There are only isolated case reports of Burkitt’s lymphoma presenting as PTLD. We present an extremely rare, aggressive Burkitt’s lymphoma years after kidney and pancreas transplantation which was successfully treated with combination chemotherapy along with withdrawal of immunosuppression. The patient remains in complete remission more than 2 years after his diagnosis. We also provide a succinct review of treatment of various PTLD and discuss the role of Epstein-Barr virus infection in the pathogenesis of PTLD
Post-transplant lymphoproliferative disorder (PTLD) complicates 1 to 10% of all transplantations. Pr...
posttransplantation lymphoproliferative disorder (PTLD) occurring within 62 days of pancreas transpl...
Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hype...
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of solid orga...
Two patients presented with post-transplant lymphoproliferative disorder (PTLD). PTLD encompasses a ...
Introduction. Post-transplant lymphoproliferative disorder (PTLD) is one of the most severe and ofte...
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantatio...
Posttransplant lymphoproliferative disorder (PTLD) is a well-recognized complication of the long-ter...
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of solid orga...
Posttransplant lymphoproliferative disorders (PTLDs) are life-threatening complications of solid-org...
Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transp...
Posttransplant lymphoproliferative disorder (PTLD) is a malignancy caused by the immunosuppression t...
comprise a histologic spectrum, ranging from hyperplastic-appearing lesions to frank non-Hodgkin’s l...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
Although post-transplant lymphoproliferative disorder is a classical complication encountered after ...
Post-transplant lymphoproliferative disorder (PTLD) complicates 1 to 10% of all transplantations. Pr...
posttransplantation lymphoproliferative disorder (PTLD) occurring within 62 days of pancreas transpl...
Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hype...
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of solid orga...
Two patients presented with post-transplant lymphoproliferative disorder (PTLD). PTLD encompasses a ...
Introduction. Post-transplant lymphoproliferative disorder (PTLD) is one of the most severe and ofte...
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantatio...
Posttransplant lymphoproliferative disorder (PTLD) is a well-recognized complication of the long-ter...
Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of solid orga...
Posttransplant lymphoproliferative disorders (PTLDs) are life-threatening complications of solid-org...
Post-transplant lymphoproliferative disorder (PTLD) is serious life-threating complication of transp...
Posttransplant lymphoproliferative disorder (PTLD) is a malignancy caused by the immunosuppression t...
comprise a histologic spectrum, ranging from hyperplastic-appearing lesions to frank non-Hodgkin’s l...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
Although post-transplant lymphoproliferative disorder is a classical complication encountered after ...
Post-transplant lymphoproliferative disorder (PTLD) complicates 1 to 10% of all transplantations. Pr...
posttransplantation lymphoproliferative disorder (PTLD) occurring within 62 days of pancreas transpl...
Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hype...